Methylation profiles of CpG island loci in major types of human cancers

Seog Yun Park, Baek-Hui Kim, Ho Kim Jeong, Nam Yun Cho, Minhee Choi, Joo Yu Eun, Sun Lee, Hoon Kang Gyeong

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Several reports have described aberrant methylation in various types of human cancers. However, the interpretation of methylation frequency in various human cancers has some limitations because of the different materials and methods used for methylation analysis. To gain an insight into the role of DNA hypermethylation in human cancers and allow direct comparison of tissue specific methylation, we generated methylation profiles in 328 human cancers, including 24 breast, 48 colon, 61 stomach, 48 liver, 37 larynx, 24 lung, 40 prostate, and 46 uterine cervical cancer samples by analyzing CpG island hypermethylation of 13 genes using methylation-specific PCR. The mean numbers of methylated genes were 6.5, 4.4, 3.6, 3.4, 3.1, 3.1, 3.1, and 2.1 in gastric, liver, prostate, larynx, colon, lung, uterine cervix, and in breast cancer samples, respectively. The number of genes that were methylated at a frequency of more than 40% in each tumor type ranged from nine (stomach) to one (breast). Generally genes frequently methylated in a specific cancer type differed from those methylated in other cancer types. The findings indicate that aberrant CpG island hypermethylation is a frequent finding in human cancers of various tissue types, and each tissue type has its own distinct methylation pattern.

Original languageEnglish
Pages (from-to)311-317
Number of pages7
JournalJournal of Korean Medical Science
Volume22
Issue number2
Publication statusPublished - 2007 Apr 1
Externally publishedYes

Fingerprint

CpG Islands
Methylation
Neoplasms
Stomach
Larynx
Genes
Prostate
Colon
Breast
Lung
Liver
Cervix Uteri
Uterine Cervical Neoplasms
Breast Neoplasms
Polymerase Chain Reaction
DNA

Keywords

  • Carcinomas
  • CpG island
  • DNA methylations
  • Tumor suppressor gene

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Park, S. Y., Kim, B-H., Jeong, H. K., Cho, N. Y., Choi, M., Eun, J. Y., ... Gyeong, H. K. (2007). Methylation profiles of CpG island loci in major types of human cancers. Journal of Korean Medical Science, 22(2), 311-317.

Methylation profiles of CpG island loci in major types of human cancers. / Park, Seog Yun; Kim, Baek-Hui; Jeong, Ho Kim; Cho, Nam Yun; Choi, Minhee; Eun, Joo Yu; Lee, Sun; Gyeong, Hoon Kang.

In: Journal of Korean Medical Science, Vol. 22, No. 2, 01.04.2007, p. 311-317.

Research output: Contribution to journalArticle

Park, SY, Kim, B-H, Jeong, HK, Cho, NY, Choi, M, Eun, JY, Lee, S & Gyeong, HK 2007, 'Methylation profiles of CpG island loci in major types of human cancers', Journal of Korean Medical Science, vol. 22, no. 2, pp. 311-317.
Park SY, Kim B-H, Jeong HK, Cho NY, Choi M, Eun JY et al. Methylation profiles of CpG island loci in major types of human cancers. Journal of Korean Medical Science. 2007 Apr 1;22(2):311-317.
Park, Seog Yun ; Kim, Baek-Hui ; Jeong, Ho Kim ; Cho, Nam Yun ; Choi, Minhee ; Eun, Joo Yu ; Lee, Sun ; Gyeong, Hoon Kang. / Methylation profiles of CpG island loci in major types of human cancers. In: Journal of Korean Medical Science. 2007 ; Vol. 22, No. 2. pp. 311-317.
@article{f8bf9398fa164905bc17f061ea97541d,
title = "Methylation profiles of CpG island loci in major types of human cancers",
abstract = "Several reports have described aberrant methylation in various types of human cancers. However, the interpretation of methylation frequency in various human cancers has some limitations because of the different materials and methods used for methylation analysis. To gain an insight into the role of DNA hypermethylation in human cancers and allow direct comparison of tissue specific methylation, we generated methylation profiles in 328 human cancers, including 24 breast, 48 colon, 61 stomach, 48 liver, 37 larynx, 24 lung, 40 prostate, and 46 uterine cervical cancer samples by analyzing CpG island hypermethylation of 13 genes using methylation-specific PCR. The mean numbers of methylated genes were 6.5, 4.4, 3.6, 3.4, 3.1, 3.1, 3.1, and 2.1 in gastric, liver, prostate, larynx, colon, lung, uterine cervix, and in breast cancer samples, respectively. The number of genes that were methylated at a frequency of more than 40{\%} in each tumor type ranged from nine (stomach) to one (breast). Generally genes frequently methylated in a specific cancer type differed from those methylated in other cancer types. The findings indicate that aberrant CpG island hypermethylation is a frequent finding in human cancers of various tissue types, and each tissue type has its own distinct methylation pattern.",
keywords = "Carcinomas, CpG island, DNA methylations, Tumor suppressor gene",
author = "Park, {Seog Yun} and Baek-Hui Kim and Jeong, {Ho Kim} and Cho, {Nam Yun} and Minhee Choi and Eun, {Joo Yu} and Sun Lee and Gyeong, {Hoon Kang}",
year = "2007",
month = "4",
day = "1",
language = "English",
volume = "22",
pages = "311--317",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "2",

}

TY - JOUR

T1 - Methylation profiles of CpG island loci in major types of human cancers

AU - Park, Seog Yun

AU - Kim, Baek-Hui

AU - Jeong, Ho Kim

AU - Cho, Nam Yun

AU - Choi, Minhee

AU - Eun, Joo Yu

AU - Lee, Sun

AU - Gyeong, Hoon Kang

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Several reports have described aberrant methylation in various types of human cancers. However, the interpretation of methylation frequency in various human cancers has some limitations because of the different materials and methods used for methylation analysis. To gain an insight into the role of DNA hypermethylation in human cancers and allow direct comparison of tissue specific methylation, we generated methylation profiles in 328 human cancers, including 24 breast, 48 colon, 61 stomach, 48 liver, 37 larynx, 24 lung, 40 prostate, and 46 uterine cervical cancer samples by analyzing CpG island hypermethylation of 13 genes using methylation-specific PCR. The mean numbers of methylated genes were 6.5, 4.4, 3.6, 3.4, 3.1, 3.1, 3.1, and 2.1 in gastric, liver, prostate, larynx, colon, lung, uterine cervix, and in breast cancer samples, respectively. The number of genes that were methylated at a frequency of more than 40% in each tumor type ranged from nine (stomach) to one (breast). Generally genes frequently methylated in a specific cancer type differed from those methylated in other cancer types. The findings indicate that aberrant CpG island hypermethylation is a frequent finding in human cancers of various tissue types, and each tissue type has its own distinct methylation pattern.

AB - Several reports have described aberrant methylation in various types of human cancers. However, the interpretation of methylation frequency in various human cancers has some limitations because of the different materials and methods used for methylation analysis. To gain an insight into the role of DNA hypermethylation in human cancers and allow direct comparison of tissue specific methylation, we generated methylation profiles in 328 human cancers, including 24 breast, 48 colon, 61 stomach, 48 liver, 37 larynx, 24 lung, 40 prostate, and 46 uterine cervical cancer samples by analyzing CpG island hypermethylation of 13 genes using methylation-specific PCR. The mean numbers of methylated genes were 6.5, 4.4, 3.6, 3.4, 3.1, 3.1, 3.1, and 2.1 in gastric, liver, prostate, larynx, colon, lung, uterine cervix, and in breast cancer samples, respectively. The number of genes that were methylated at a frequency of more than 40% in each tumor type ranged from nine (stomach) to one (breast). Generally genes frequently methylated in a specific cancer type differed from those methylated in other cancer types. The findings indicate that aberrant CpG island hypermethylation is a frequent finding in human cancers of various tissue types, and each tissue type has its own distinct methylation pattern.

KW - Carcinomas

KW - CpG island

KW - DNA methylations

KW - Tumor suppressor gene

UR - http://www.scopus.com/inward/record.url?scp=34248504607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248504607&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 311

EP - 317

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 2

ER -